retatrutide type 2 diabetes phase 2 results 2024 ada Efficacy and safety of retatrutide, a GIP Lilly's triple agonist achieves 16.8%
Pay in 4 interest-free payments of $7.46 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Nov 6 - Nov 11



























